Michael K. Hansen

5.4k total citations · 1 hit paper
81 papers, 3.8k citations indexed

About

Michael K. Hansen is a scholar working on Endocrinology, Diabetes and Metabolism, Molecular Biology and Surgery. According to data from OpenAlex, Michael K. Hansen has authored 81 papers receiving a total of 3.8k indexed citations (citations by other indexed papers that have themselves been cited), including 32 papers in Endocrinology, Diabetes and Metabolism, 22 papers in Molecular Biology and 20 papers in Surgery. Recurrent topics in Michael K. Hansen's work include Diabetes Treatment and Management (27 papers), Pancreatic function and diabetes (15 papers) and Neuroinflammation and Neurodegeneration Mechanisms (11 papers). Michael K. Hansen is often cited by papers focused on Diabetes Treatment and Management (27 papers), Pancreatic function and diabetes (15 papers) and Neuroinflammation and Neurodegeneration Mechanisms (11 papers). Michael K. Hansen collaborates with scholars based in United States, Australia and United Kingdom. Michael K. Hansen's co-authors include Steven F. Maier, Linda R. Watkins, James M. Krueger, Lisa E. Goehler, Kevin O’Connor, Ron P.A. Gaykema, Hiddo J.L. Heerspink, John D. Johnson, Zutang Chen and Ping Taishi and has published in prestigious journals such as Circulation, Journal of Neuroscience and Journal of the American College of Cardiology.

In The Last Decade

Michael K. Hansen

77 papers receiving 3.7k citations

Hit Papers

align trajectories

What are hit papers?

Hit papers significantly outperform the citation benchmark for their cohort. A paper qualifies if it has ≥500 total citations, achieves ≥1.5× the top-1% citation threshold for papers in the same subfield and year (this is the minimum needed to enter the top 1%, not the average within it), or reaches the top citation threshold in at least one of its specific research topics.

Canagliflozin reduces inflammation and fibrosis biomarkers: a potential mechanism of action for beneficial effects of SGLT2 inhibitors in diabetic kidney disease

2019 340 citations Hiddo J.L. Heerspink, Michael K. Hansen et al. profile →

Peers — A (Enhanced Table)

Peers by citation overlap · career bar shows stage (early→late) cites · hero ref

Name	h						Papers	Cites
Michael K. Hansen United States	33	974	938	803	635	602	81	3.8k
Christopher D. Breder United States	23	1.6k 1.7×	655 0.7×	653 0.8×	534 0.8×	295 0.5×	37	4.9k
David Engblom Sweden	32	1.1k 1.1×	485 0.5×	454 0.6×	513 0.8×	196 0.3×	74	3.7k
Robert B. Felder United States	41	1.0k 1.0×	686 0.7×	469 0.6×	724 1.1×	828 1.4×	114	5.0k
Ana Marı́a Genaro Argentina	30	787 0.8×	678 0.7×	201 0.3×	507 0.8×	326 0.5×	96	2.8k
Paul J. Pistell United States	19	711 0.7×	875 0.9×	404 0.5×	172 0.3×	169 0.3×	31	2.3k
Borja García‐Bueno Spain	40	1.1k 1.1×	668 0.7×	1.2k 1.6×	1.2k 1.9×	177 0.3×	94	4.5k
Alyson A. Miller Australia	33	643 0.7×	1.1k 1.2×	768 1.0×	140 0.2×	429 0.7×	53	3.3k
Suneil K. Koliwad United States	29	1.4k 1.4×	1.3k 1.4×	656 0.8×	120 0.2×	430 0.7×	64	4.4k
Thoralf Wendt Germany	21	983 1.0×	640 0.7×	398 0.5×	349 0.5×	1.4k 2.4×	33	4.8k
Abdeslam Mouihate Canada	24	371 0.4×	326 0.3×	433 0.5×	560 0.9×	199 0.3×	62	3.0k

Countries citing papers authored by Michael K. Hansen

Since Specialization

Citations

This map shows the geographic impact of Michael K. Hansen's research. It shows the number of citations coming from papers published by authors working in each country. You can also color the map by specialization and compare the number of citations received by Michael K. Hansen with the expected number of citations based on a country's size and research output (numbers larger than one mean the country cites Michael K. Hansen more than expected).

Fields of papers citing papers by Michael K. Hansen

Since Specialization

Physical SciencesHealth SciencesLife SciencesSocial Sciences

This network shows the impact of papers produced by Michael K. Hansen. Nodes represent research fields, and links connect fields that are likely to share authors. Colored nodes show fields that tend to cite the papers produced by Michael K. Hansen. The network helps show where Michael K. Hansen may publish in the future.

Co-authorship network of co-authors of Michael K. Hansen

This figure shows the co-authorship network connecting the top 25 collaborators of Michael K. Hansen. A scholar is included among the top collaborators of Michael K. Hansen based on the total number of citations received by their joint publications. Widths of edges represent the number of papers authors have co-authored together. Node borders signify the number of papers an author published with Michael K. Hansen. Michael K. Hansen is excluded from the visualization to improve readability, since they are connected to all nodes in the network.

All Works

Sort: Min cites: Since: Top N: Style:

20 of 20 papers shown

Januzzi, James L., Yuxi Liu, Naveed Sattar, et al.. (2024). Vascular endothelial growth factors and risk of cardio-renal events: Results from the CREDENCE trial. American Heart Journal. 271. 38–47. 3 indexed citations

Khan, Muhammad Shahzeb, James L. Januzzi, Yuxi Liu, et al.. (2024). Natriuretic Peptides and Prognosis in Patients With Type 2 Diabetes Mellitus and High Risk for Cardiovascular Events. Journal of Cardiac Failure. 30(12). 1544–1551. 2 indexed citations

Mohebi, Reza, Yuxi Liu, Michael K. Hansen, et al.. (2023). Associations of Angiopoietin 2 and Vascular Endothelial Growth Factor-A Concentrations with Clinical End Points. Clinical Journal of the American Society of Nephrology. 19(4). 429–437. 5 indexed citations

Sen, Taha, Wenjun Ju, Viji Nair, et al.. (2023). Sodium glucose co-transporter 2 inhibition increases epidermal growth factor expression and improves outcomes in patients with type 2 diabetes. Kidney International. 104(4). 828–839. 16 indexed citations

Neuen, Brendon L., Megumi Oshima, Tadashi Toyama, et al.. (2023). Autoantibodies to Erythropoietin Receptor and Clinical Outcomes in Patients With Type 2 Diabetes and CKD: A Post Hoc Analysis of CREDENCE Trial. Kidney International Reports. 9(2). 347–355. 1 indexed citations

Vaduganathan, Muthiah, Naveed Sattar, Javed Butler, et al.. (2022). Stress Cardiac Biomarkers, Cardiovascular and Renal Outcomes, and Response to Canagliflozin. Journal of the American College of Cardiology. 79(5). 432–444. 27 indexed citations

Ferrannini, Giulia, Norman Rosenthal, Michael K. Hansen, & Ele Ferrannini. (2022). Liver function markers predict cardiovascular and renal outcomes in the CANVAS Program. Cardiovascular Diabetology. 21(1). 127–127. 5 indexed citations

Snider, Julia Thornton, Jeffrey Sullivan, Michael K. Hansen, et al.. (2019). Lifetime benefits of early detection and treatment of diabetic kidney disease. PLoS ONE. 14(5). e0217487–e0217487. 31 indexed citations

Qi, Jenson, Wensheng Lang, Margery A. Connelly, et al.. (2016). Metabolic tracing of monoacylglycerol acyltransferase-2 activity in vitro and in vivo. Analytical Biochemistry. 524. 68–75. 1 indexed citations

10.

Connor, Susan C., et al.. (2010). Integration of metabolomics and transcriptomics data to aid biomarker discovery in type 2 diabetes. Molecular BioSystems. 6(5). 909–921. 162 indexed citations

11.

Hansen, Michael K., Niroz Abu‐Saleh, Zaid Abassi, et al.. (2010). Peroxisome Proliferator-Activated Receptor Alpha and Alpha/Gamma Agonists Do Not Cause Impairment in Renal Function in the Rat. Nephron Physiology. 115(3). p21–p30. 3 indexed citations

12.

Tatsuoka, Kay, Bahrad A. Sokhansanj, Michael K. Hansen, et al.. (2008). Multi-platform investigation of the metabolome in a leptinreceptor defective murine model of type 2 diabetes. Molecular BioSystems. 4(10). 1015–1023. 21 indexed citations

13.

Hansen, Michael K. & Thomas Connolly. (2008). Nuclear receptors as drug targets in obesity, dyslipidemia and atherosclerosis.. PubMed. 9(3). 247–55. 57 indexed citations

14.

Holguin, Adelina, Kevin O’Connor, Joseph C. Biedenkapp, et al.. (2004). HIV-1 gp120 Stimulates proinflammatory cytokine-mediated pain facilitation via activation of nitric oxide synthase-I (nNOS). Pain. 110(3). 517–530. 84 indexed citations

15.

Campisi, Jay, Michael K. Hansen, Kevin O’Connor, et al.. (2003). Circulating cytokines and endotoxin are not necessary for the activation of the sickness or corticosterone response produced by peripheralE. colichallenge. Journal of Applied Physiology. 95(5). 1873–1882. 46 indexed citations

16.

Gaykema, Ron P.A., Lisa E. Goehler, Michael K. Hansen, Steven F. Maier, & L.R. Watkins. (2000). Subdiaphragmatic vagotomy blocks interleukin-1β-induced fever but does not reduce IL-1β levels in the circulation. Autonomic Neuroscience. 85(1-3). 72–77. 25 indexed citations

17.

Watkins, Linda R., Michael K. Hansen, Kien T. Nguyen, Jacqueline E. Lee, & Steven F. Maier. (1999). Dynamic regulation of the proinflammatory cytokine, interleukin-1β: Molecular biology for non-molecular biologists. Life Sciences. 65(5). 449–481. 107 indexed citations

18.

Taishi, Ping, Zutang Chen, Ferenc Obál, et al.. (1998). Sleep-Associated Changes in Interleukin-1β mRNA in the Brain. Journal of Interferon & Cytokine Research. 18(9). 793–798. 72 indexed citations

19.

Shalmi, Michael, et al.. (1990). Tetraethylammonium and <i>ρ</i><i>-</i>Aminohippurate as Clearance Markers for Renal Plasma Flow in the Rat during Saline and Glucose Infusion. Kidney & Blood Pressure Research. 13(6). 314–323. 13 indexed citations

20.

Hansen, Michael K., et al.. (1981). True and False Foodplants of Callosamia Promethea (Lepidoptera: Saturniidae) in Southern Michigan. The Great Lakes Entomologist. 14(3). 6. 6 indexed citations

Rankless uses publication and citation data sourced from OpenAlex, an open and comprehensive bibliographic database. While OpenAlex provides broad and valuable coverage of the global research landscape, it—like all bibliographic datasets—has inherent limitations. These include incomplete records, variations in author disambiguation, differences in journal indexing, and delays in data updates. As a result, some metrics and network relationships displayed in Rankless may not fully capture the entirety of a scholar's output or impact.

Explore authors with similar magnitude of impact